Written by Ad OpsIntroduction
CBD OG Kush is a purposeful reinterpretation of the famed OG Kush, engineered to emphasize cannabidiol (CBD) while keeping the cultivar’s unmistakable Kush character. Bred by Scott Family Farms, this hybrid retains the indica/sativa heritage of the original lineage yet shifts the chemotype toward calmer, clearer effects. For consumers who love OG’s diesel-citrus-pine bouquet but want significantly less intoxication, CBD OG Kush is a compelling fit.
Across seed vendors, this cultivar is generally categorized as a hybrid with low to minimal THC and appreciable CBD content. Listings at SeedSupreme show “CBD OG Kush Feminized” positioned among medical and high-CBD categories, with THC described as minimum (0–5%) or low (5–10%). Those ranges suggest a Type II (balanced) to Type III (CBD-dominant) chemotype depending on phenotype and batch.
The sensory profile remains faithful to classic OG Kush cues—earthy, fuel-forward base notes lifted by lemon-lime zest and forest pine. CBD-forward expressions often soften the sharper edges of the high while preserving the dense trichome coverage and terpene saturation Kush fans expect. The result is a cultivar that reads like OG on the nose and tongue, yet lands like a steadier, more functional companion in practice.
This article digs deep into CBD OG Kush’s background, chemistry, and cultivation. It blends breeder attribution, widely reported OG lineage theories, and vendor-side data with practical grower and patient guidance. The goal is clarity: what to expect from seed to jar to session, supported by specific ranges, milestones, and best practices.
Origins_and_Breeding_History
OG Kush’s backstory is famously contested, and that uncertainty sets the stage for CBD OG Kush’s modern rework. One of the most-circulated theories—summarized by outlets like CannaConnection—traces OG to Chemdawg combined with Lemon Thai and Pakistani (Hindu) Kush lines. Whatever the exact recipe, OG Kush surged from the 1990s U.S. underground to global staple, prized for loud aroma and potent, often heavy-handed effects.
CBD OG Kush retains that heritage while deliberately dialed back on THC. Scott Family Farms is credited with stabilizing this CBD-rich phenotype, aligning the cultivar with today’s therapeutic and wellness markets while honoring OG’s sensory DNA. The intent is straightforward: deliver OG’s iconic flavor and structure in a composition that more people can use during the day or for symptom relief without intense intoxication.
Vendor listings reinforce the chemotype shift. On SeedSupreme, CBD OG Kush Feminized appears in both medical and high-CBD categories with pricing at around $55 per pack during various promotions, signaling broad accessibility. THC is repeatedly described as minimal (0–5%) or low (5–10%), which is in line with a CBD-forward adaptation rather than a THC-centric powerhouse.
The precise CBD donor used by Scott Family Farms has not been publicly standardized across sources, and reputable databases treat the cross as a CBD-forward OG expression rather than naming a single, universal CBD parent. In practice, breeders often work with CBD-rich progenitors—such as long-used CBD donor pools—to backcross flavor and structure into a safer psychotropic envelope. The outcome is less about one named parent and more about the repeatable chemotype goal: Kush flavor, calmer head, and wider therapeutic window.
In consumer markets, CBD OG Kush has increasingly been slotted alongside other CBD-modified classics like CBD Chemdog and CBD Girl Scout Cookies. That positioning matters because it frames expectations around function and compliance, from wellness regimens to markets where lower-THC products face fewer restrictions. It also pushes the conversation from pure potency toward precision: flavor fidelity, consistent ratios, and predictable effects.
Genetic_Lineage_and_Chemotype
CBD OG Kush sits within indica/sativa hybrid territory, expressing structural and terpene traits recognizable to longtime Kush growers. The genetic scaffolding reflects OG Kush ancestry—broadleaf-leaning density, fuel-citrus aromatics, and a resin-forward calyx. The CBD enhancement modifies experience more than morphology, reshaping the cannabinoid ratio while conserving the cultivar’s sensory hallmarks.
Because Scott Family Farms has not universally publicized a singular CBD donor in widely cited sources, the best description is a CBD-rich OG Kush selection stabilized for low-to-moderate THC. Breeding programs targeting CBD often seek Type II (roughly 1:1 THC:CBD) or Type III (CBD-dominant with ≤1% THC in finished flower) outcomes. CBD OG Kush, based on vendor reports, commonly occupies a middle ground—THC minimal-to-low with CBD that substantially outpaces THC.
SeedSupreme’s product pages describe THC as minimum (0–5%) in one listing and low (5–10%) in another, which underscores phenotype and grow-dependent variability. In CBD-forward OG lines, it is typical to find CBD in the 8–15% range by dry weight under competent cultivation, though exact lab outcomes vary by genotype, environment, and cure. That positioning puts CBD OG Kush squarely into the utility zone for daytime symptom management while maintaining OG-style flavor intensity.
Chemotypically, this cultivar is designed to blunt THC’s overt psychoactivity without dulling engagement. CBD acts as a negative allosteric modulator at CB1, and human data show it can mitigate some THC-associated adverse effects like anxiety and tachycardia. In a practical sense, that means CBD OG Kush often feels clearer, with less short-term memory disruption and fewer spikes in heart rate compared with classic high-THC OG cuts at equivalent inhaled volumes.
From a grower standpoint, phenotypic selection can tilt the final ratio notably. Seeds may segregate across a spectrum, yielding Type II flowers in one plant and more CBD-dominant Type III expressions in a sibling. Clonal propagation from a verified mother with known lab results remains the gold standard for ratio consistency, especially when products must meet regulatory THC thresholds.
Appearance_and_Bud_Structure
Visually, CBD OG Kush mirrors its THC-heavy ancestor with dense, golf-ball to tapering spear-shaped flowers. Calyxes stack tightly, producing a high calyx-to-leaf ratio that trims efficiently once fully mature. Bracts are thick and resin-draped, often bright lime to olive green with copper to tangerine pistils.
Trichome coverage is copious, with bulbous-cap and stalked glandular heads forming a frosty veneer across bracts and sugar leaves. Under magnification, mature heads turn cloudy en masse before ambering around edges at later ripeness. This heavy gland development signals both terpene saturation and target cannabinoid maturity, and it contributes to the cultivar’s sticky, tacky hand-feel on harvest day.
Plants typically remain medium in stature indoors, showing nodal spacing that tightens under strong lighting and careful climate control. Fan leaves can present with broadleaf indica traits while still accommodating training without excessive brittleness. In cooler rooms late in flower, some phenotypes may flash subtle lavender hues at leaf tips, a response tied to anthocyanin expression rather than a marker for CBD content.
Finished buds dry down to a firm, slightly springy texture when properly cured, with minimal stem chatter. The best examples keep their shape in jars, shed sugar leaves cleanly, and display a granular, shimmering resin coat. Consumers often note that the physical look is “pure OG,” and it is the subsequent effect—not the aesthetic—that differentiates the CBD variant.
Aroma_and_Flavor_Profile
CBD OG Kush remains faithful to the OG palette, leading with gassy, diesel-like volatility that sits atop a citrus-pine spine. Freshly ground flowers push bright lemon-lime zest, while the broken stem or sap lends earthy, camphor-like undertones. A sweet-bitter grapefruit echo sometimes rides the exhale, a sensory motif shared with many OG-family cuts.
Dominant terpenes that commonly support this profile include myrcene, limonene, and beta-caryophyllene, with pinene and humulene appearing as frequent co-stars. Myrcene contributes the earthy, slightly musky bass line; limonene lifts with citrus; and beta-caryophyllene layers peppery spice that reads as diesel-adjacent in complex mixtures. In balanced proportions, this trio explains why OG profiles feel simultaneously dense and refreshing on the palate.
Combustion preserves the core gas-citrus character at the cost of some floral top notes, whereas vaporization at 170–190°C heightens lemon and pine while muting bitterness. Cold-cured rosin or solventless extracts from CBD OG Kush can amplify the diesel qualities significantly, sometimes overshadowing the citrus. Edible infusions carry over a mellow earth-citrus essence when decarbed gently at 105–115°C for 30–45 minutes prior to incorporation.
It is important to underline that CBD enrichment does not inherently change terpene synthesis pathways; environment and phenotype do. Grow room factors like light intensity, nutrient balance, and post-harvest curing often shift aroma intensity more than cannabinoid ratio alone. As a result, an expertly grown CBD OG Kush can smell louder and read “more OG” than a poorly finished high-THC OG, despite lower THC content.
Consumers who prefer a smoother finish should explore lower-temperature vaporization, which reduces harsh resin burn and preserves limonene’s brightness. Conversely, those chasing the traditional OG “punch” frequently favor hotter draws and shorter pulls to concentrate the diesel kick. Either way, CBD OG Kush’s aromatic fidelity is a defining asset that bridges medical and connoisseur communities.
Cannabinoid_Profile_and_Lab_Expectations
Vendor information positions CBD OG Kush as a CBD-forward hybrid with minimal-to-low THC. SeedSupreme catalogs list THC as minimum (0–5%) in some entries and low (5–10%) in others, which reflects phenotype spread and cultivation factors. In practical lab terms, that equates to roughly 0–100 mg THC per gram of flower, with many lots clustering toward the bottom half of that range in CBD-dominant phenotypes.
CBD content typically outpaces THC and is often reported in the 8–15% range by dry weight when grown under optimized indoor conditions. Translating that to labs, one might expect 80–150 mg CBD per gram, though real-world results may present higher or lower depending on genotype and environmental dialing. Balanced Type II expressions can also appear in the 5–10% THC and 5–10% CBD neighborhood, producing near 1:1 ratios with subdued intoxication compared to standard OG Kush.
Minor cannabinoids usually register in measurable but modest quantities. CBG often ranges 0.1–1.0% in CBD-rich flowers, reflecting incomplete CBGA conversion and genotype-specific flux. CBC may appear around 0.1–0.6% in well-developed resin, and trace THCV or CBDV can be present depending on parental contribution.
When calculating dose, decarboxylation efficiency matters. In smoking or vaporization, THCA and CBDA are largely converted to THC and CBD, but thermal loss can reduce the total available fraction by 10–20% depending on technique. For edibles, controlled decarb (for example, 115°C for 40 minutes) routinely yields over 80% conversion efficiency with minimal terpene loss when performed in closed vessels.
CBD’s presence modulates subjective response beyond the raw milligram math. Human and animal studies indicate CBD can attenuate THC-induced anxiety and transient tachycardia through CB1 modulation and serotonergic pathways. For consumers, this means that two samples with identical THC numbers can feel noticeably different if one carries substantial CBD.
Because ratio accuracy is central to both therapeutic use and legal compliance, lab verification remains best practice. Growers aiming for CBD-dominant flower in jurisdictions with strict THC caps should phenotype-hunt and test multiple candidates, retaining mothers that consistently present ≤1% THC with robust CBD output. Patients seeking repeatable effects should favor batches with certificates of analysis that specify cannabinoids by mg/g alongside terpene breakdowns.
Terpene_Profile_and_Aroma_Mechanics
CBD OG Kush’s terpene profile typically echoes OG Kush dominance in myrcene, limonene, and beta-caryophyllene, with meaningful support from alpha- and beta-pinene and humulene. In well-grown indoor flowers, total terpene content often falls between 1.5% and 3.5% by dry weight, a range consistent with aromatic, connoisseur-grade cannabis. Individual terpene percentages vary, but myrcene commonly lands around 0.3–1.2%, limonene 0.2–0.8%, and beta-caryophyllene 0.2–1.0% in representative lab panels for OG-type chemovars.
Myrcene is frequently cited for its earthy-musk aroma and potential to synergize sedative experience, though controlled human data remain limited. Limonene is associated with citrus brightness and has been studied for mood-elevating and stress-mitigating properties. Beta-caryophyllene is notable as a dietary terpene that selectively agonizes CB2 receptors, offering a mechanistic pathway for anti-inflammatory effect without central intoxication.
Pinene contributes a crisp pine character with anecdotally reported benefits for alertness and countering memory fog. Humulene layers woody, hop-like dryness and has been investigated for anti-inflammatory and appetite-modulating actions in preclinical models. Linalool, ocimene, and terpinolene can appear in trace-to-minor amounts depending on phenotype, occasionally nudging the profile toward floral or herbal edges.
Terpene retention is highly sensitive to post-harvest handling. Drying at 18–20°C with 55–60% relative humidity over 10–14 days preserves monoterpenes better than fast, hot dries, where limonene and pinene losses can exceed 30%. Curing in airtight containers with periodic burping for 3–4 weeks further integrates volatile layers and stabilizes flavor.
From a consumer standpoint, vaporization temperature curves can selectively emphasize different components. Setting devices near 175–185°C elevates limonene and pinene perception with a brighter, cleaner hit, while 195–205°C pulls more of the heavier sesquiterpenes like caryophyllene and humulene. Because CBD OG Kush delivers its “OG identity” through this terpene matrix, dialing temperature is an effective way to fine-tune the experience.
Growers targeting a terpene-forward harvest should prioritize light quality, gentle late-flower feeding, and minimal leaf damage. High PPFD with balanced blue-red spectra, modest night temperature drops, and careful humidity control all correlate with better volatile retention. Equally, avoiding over-drying and rough manicuring protects the very trichome heads that concentrate aroma.
Experiential_Effects_and_Use_Cases
The hallmark of CBD OG Kush is an OG-like sensory journey coupled with a steadier, clearer effect profile. Initial onset after inhalation typically arrives within 1–3 minutes, with a gentle body ease and muted head change that plateaus by 10–15 minutes. Instead of an overpowering couch-lock, users often describe a composed calm with comfortable muscle relaxation and reduced stress signaling.
Because THC is minimal-to-low, racing thoughts, short-term memory disruption, and heart-rate spikes—common complaints with strong OG phenotypes—tend to be rarer. CBD’s presence supports a more linear, predictable arc that fits daytime or task-oriented contexts. Many users note that social ease improves without the disinhibition or intoxication that can complicate work or family routines.
Flavor-forward sessions are a major draw, and CBD OG Kush obliges with diesel-citrus richness in small, repeatable doses. Typical inhaled servings range from 1–3 small puffs for novice users and 3–6 for experienced users seeking deeper body relief without loss of clarity. For oral use, 10–25 mg CBD from decarbed flower infusions is a common starter range, adjusted upward cautiously based on response.
Performance settings like light exercise, stretching, or creative tasks often pair well with this cultivar. The body relaxation tracks with reduced “background noise” discomforts—minor aches, subclinical headache pressure, or pre-meeting jitters—while the head remains oriented. For sleep, some users find that a slightly higher dose taken 60–90 minutes pre-bed smooths transition without grogginess the next morning.
Side effects are generally mild when dosing remains conservative. Dry mouth and dry eyes can still occur, and very sensitive individuals may feel subtle dizziness if over-inhaled. As with any inhaled product, those with respiratory conditions should weigh non-combustion routes like vaporization or edibles to minimize irritant exposure.
Potential_Medical_Applications
CBD OG Kush’s appeal in clinical and wellness circles rests on its cannabinoid ratio and terpene synergy rather than sheer THC potency. CBD’s evidence base has expanded markedly in the past decade, with randomized trials supporting prescription formulations at 10–20 mg/kg/day for rare epilepsies and open-label or smaller trials exploring anxiety, sleep, and pain. While whole-plant cannabis differs from isolated CBD, these data inform dose ceilings and safety windows for CBD-rich chemovars.
Anxiety-related use is common in community settings, and mechanistic studies suggest CBD modulates 5-HT1A receptors and dampens amygdala hyperreactivity. Human experiments have observed reduced anxiety during public speaking tasks at acute oral doses around 300–600 mg CBD, albeit far above typical inhaled servings. In practice, many patients report meaningful anxiolysis from repeated, smaller doses that accumulate across the day, particularly when paired with caryophyllene- and limonene-rich terpene profiles.
Pain and inflammation represent another key application area. Systematic reviews of cannabinoids for chronic pain show modest-to-moderate effect sizes, with CBD’s anti-inflammatory action and caryophyllene’s CB2 agonism offering a non-intoxicating route to symptom relief. For musculoskeletal discomfort, users often find benefit at 20–100 mg/day CBD spread across intervals, supplemented by topical application of infused balms targeting localized flare-ups.
Sleep disturbances often improve indirectly when daytime anxiety and pain are reduced. For primary insomnia, some patients describe smoother sleep initiation with CBD OG Kush taken 60–120 minutes before bed, especially when vaporized at lower temperatures to highlight myrcene and linalool traces. Importantly, lower THC helps minimize next-day grogginess and REM suppression sometimes associated with sedative THC doses.
Neurological and inflammatory conditions are frequent drivers of CBD exploration. While robust randomized controlled trials are still needed for many indications, preclinical data support CBD’s neuroprotective, antioxidant, and anti-inflammatory properties via PPAR-γ activation, TRPV1 modulation, and adenosine signaling. Whole-plant matrices may further potentiate these effects through entourage interactions among terpenes and minor cannabinoids.
Respiratory considerations warrant a nuanced view. A SeedSupreme blog highlighting strains discussed for asthma relief includes CBD OG Kush among other CBD-forward options, but clinicians generally caution against combusted routes for asthma due to airway irritation. Vaporization at controlled temperatures or oral tinctures and capsules are preferred delivery methods, allowing patients to explore anti-inflammatory benefits without smoke exposure.
As always, individual response varies, and drug–drug interactions are a real consideration at higher CBD doses, especially with CYP3A4 and CYP2C19 substrates. Patients using anticoagulants, antiepileptics, or antidepressants should consult a medical professional before sustained high-CBD regimens. Certificates of analysis and batch-level transparency remain best practices to ensure ratio accuracy and contaminant-free medicine.
Comprehensive_Cultivation_Guide
CBD OG Kush grows like an OG at heart, rewarding attentive cultivators with terpene-dense, trichome-heavy flowers and a saner cannabinoid ratio. Indoors, expect a medium build with responsive branching and a canopy that benefits from training. Outdoors, the plant prefers warm, dry finishes and consistent airflow to stave off powdery mildew.
Seeds from vendors like SeedSupreme are typically feminized, streamlining garden planning, with listings tagging this cultivar as a hybrid and marking it in medical/high-CBD categories. Germination follows standard best practices: 24–72 hours in moist, oxygenated media at 22–25°C, then transplant to lightly fertilized substrate once the radicle emerges 0.5–1.0 cm. Early vigor is steady rather than explosive, which lends itself to calm training in week 2–3 of veg.
Substrate choices range from high-quality peat/coco blends to living soil, with each route having specific management needs. In coco and soilless media, target pH 5.8–6.0 in veg and 6.0–6.2 in flower, with EC ramping from 1.2–1.6 in veg to 1.8–2.2 in peak bloom. In mineralized soil, aim for pH 6.2–6.5 and feed lightly; OG frames, including CBD versions, dislike heavy early nitrogen and appreciate steady calcium–magnesium support.
Environmentally, OG-type resin engines favor stable VPD and strong, non-stressful light. In veg, temps of 24–27°C with 60–70% RH and PPFD of 300–500 μmol/m²/s encourage dense node spacing. In flower, shift to 24–26°C day and 19–21°C night, 45–55% RH, and PPFD of 700–900 μmol/m²/s, keeping leaf surface temperature within 1–2°C of air to avoid photoinhibition.
Training techniques that consistently pay off include topping once or twice between nodes 4–6, followed by low-stress training to open the canopy. A simple two-top mainline or a horizontal ScrOG can raise usable canopy area and even out apical dominance. Many growers report 15–25% yield improvements with methodical training versus single-cola runs, especially in tents under 200–600 W LED fixtures.
Flowering time generally lands around 8–9 weeks indoors for most CBD OG Kush phenotypes, in line with OG heritage timelines. Outdoors in temperate zones, plan for late September to early October harvest before heavy autumn moisture. As with all OGs, late-season humidity spikes invite powdery mildew; keep airflow high, maintain 45–50% RH in late bloom, and avoid large temperature swings at lights-off.
Nutritionally, a moderate nitrogen veg feed and a phosphorus–potassium tilt in weeks 3–7 of flower promote full calyx swell. Don’t starve calcium and magnesium—OG frames are notoriously calcium-hungry once high light levels are applied. Monitor runoff EC and leaf tissue; clawing or deep green gloss signals excess N, while interveinal chlorosis and brittle leaves suggest Cal–Mag shortfalls.
Watering cadence should aim for rhythmic wet–dry cycles without severe drought. In 3–5 gallon containers, plants in late veg may take 1–2 liters per day; in peak flower under high PPFD, 2–4 liters per day is common depending on media and pot size. Maintain at least 10–15% runoff in inert media to prevent salt buildup, and adjust irrigation volume if runoff EC creeps above target.
Integrated pest management is essential. Sticky cards, weekly scouting, and prophylactic biologicals like Bacillus subtilis and Beauveria bassiana help keep PM and soft-bodied pests in check. Sanitation—clean intakes, leaf litter removal, and tool sterilization—cuts disease pressure before it starts.
Ripeness assessment should prioritize trichome observation over calendar days. For a brighter, daytime CBD expression, many growers harvest around 5–10% amber with the majority cloudy, preserving limonene brightness and minimizing sedative drift. For a slightly heavier body effect, ride to 15–20% amber across upper colas while ensuring lowers are at least fully cloudy.
Yields vary by cut, training, and environment, but indoor ranges of 350–500 g/m² are attainable under competent LED lighting and dialed climates. Outdoors, healthy plants in 20–50 gallon beds with full sun and low disease pressure can produce 400–650 g per plant. CO₂ enrichment to 800–1,200 ppm in sealed rooms can add 20–30% biomass if light, nutrition, and irrigation are balanced.
Drying and curing protocols heavily influence terpene retention and perceived potency. Target 10–14 days at 18–20°C and 55–60% RH until small stems snap, then trim and jar. Cure at 58–62% RH for 3–4 weeks, burping daily for the first 7–10 days; this routine preserves the diesel-citrus ensemble that defines the cultivar.
For hashmakers, CBD OG Kush can yield well to ice water extraction when grown clean and harvested at optimal resin maturity. The bulbous, sturdy heads typical of OG lines wash competently, with 73–120 μm fractions often carrying the richest aroma. Fresh frozen preserves more top-note monoterpenes, while dried-cure inputs emphasize fuel and spice.
Finally, phenotype selection is pivotal if you are targeting a specific ratio or compliance threshold. Run 6–10 seeds where possible, label meticulously, and send representative flowers for third-party analysis before committing to a mother. Lock in the keeper that consistently tests with the CBD:THC balance you need—whether a near 1:1 for broader effect or a CBD-dominant expression that keeps THC in the “minimum (0–5%)” bracket cited by vendor listings.
